Breakthrough Psychedelics
Breakthrough Psychedelics is an educational journey into the re-emerging world of psychedelic therapies, offering a comprehensive exploration of three breakthrough psychedelics: MDMA, psilocybin, and ketamine.
Course Overview
Breakthrough Psychedelics is an educational journey into the re-emerging world of psychedelic therapies, offering a comprehensive exploration of three breakthrough psychedelics: MDMA, psilocybin, and ketamine. As these substances gain recognition for their potential therapeutic applications, this course provides valuable insights into their clinical science, pharmacology, and contextual use. Whether you are a healthcare professional seeking to incorporate this knowledge into client care or a curious individual interested in understanding the fascinating realm of psychedelics, this course offers a deep dive into these substances' core principles, safety profiles, and therapeutic potential.
Structured into six sections with bite-sized modules, this course allows learners to progress at their own pace, providing approximately seven hours of online home study for completion. From exploring the fundamentals of psychedelics and their impact on mental and physical illnesses to delving into the neurobiology of psychedelics, participants will develop a solid foundation in the pharmacodynamics and pharmacokinetics of MDMA, psilocybin, and ketamine.
The course also covers potential uses and indications, safety profiles, adverse effects, and drug interactions. By the end of the course, learners will gain a comparative understanding of these three breakthrough psychedelics and explore various contexts of use, including self or home use, ritual use, and psychedelic-assisted therapy.
Who is this for?
Healthcare professionals, mental health professionals, and learners interested in the clinical science and use of psychedelic therapies.
About the Provider
Benjamin Malcolm's psychedelic pharmacology education and consulting platform offering continuing education courses for healthcare professionals on safe psychedelic therapy practices. Spirit Pharmacist bridges evidence-based pharmacology with clinical psychedelic practice through online courses, consulting services, and harm reduction resources.
View Spirit Pharma profileCourse Details
- Price$97
- FormatSelf-paced
- Lifecycle statusNo New Dates
- Skillsclinical sciencepharmacologycontextual usecore principlespharmacodynamicspharmacokineticsdrug interactiontoleranceaddiction potentialsafetyadverse effectstoxicologymystical experienceFacilitation
- Categories
You will be redirected to the provider's website
Related Courses
View all coursesAdd Spravato® To Your Practice with our 8-Phases Implementation Roadmap
Spravato FastTrack is an implementation course for clinics that want to add Spravato (esketamine) services. It covers REMS certification, procurement, prior authorization, billing, documentation, and related operational steps.
Automated status check: No valid upcoming cohort date found on the source page (checked 2026-04-15).
Certificate in Psychedelic-Assisted Therapies & Research | CIISCIIS LogoCIIS Logo
A 12-month certificate in psychedelic-assisted therapies and research offered by CIIS. The program includes hybrid or online study and covers clinical competencies, research, cultural context, and ethical practice.
Curriculum
A curriculum focused on psilocybin, MDMA, and ketamine facilitation for spiritual and psychotherapeutic care. It was grounded in inclusion, reciprocity, and respect, and combined scientific, ancestral, and communal perspectives.
Automated status check: No valid upcoming cohort date found on the source page (checked 2026-04-15).